In vitro investigation of aluminum and fluoride release from compomers, conventional and resin-modified glass-ionomer cements: a standardized approach.
The amount of fluoride release from dental cements necessary for an anticariogenic effect is not established: moreover, the possible toxic effects due to high fluoride and aluminum release are not well known and the results are still controversial. The aim of our study was to evaluate fluoride (F) and aluminum (Al) release from dental cements using a 'standardized approach' according to the end-use of the materials, i.e. biocompatibility testing. Two polyacid-modified resin composites of recent application, commonly called compomers (Dyract and Dyract Cem), were compared with two conventional acid-based (Fuji I, Ketac-Cem) and two resin-modified (Vitremer, Vitrebond) glass-ionomer cements (GICs). All types of cement are used in dentistry and are commercially available. Extracts of the cements into minimum essential medium, after setting over a 1-h (group A) and 1-week (group B) period, were performed. The extraction conditions were rigorously standardized. Mean values +/- standard deviation of F- and Al-levels in such extracts were measured and were expressed as microg g(-1) (micrograms of ions per gram of cement). A great difference in the amount of ion release, both F and Al, was shown among the tested materials. The GICs, as well as Ketac-Cem, released more F and Al than the compomers. All of the materials released the greatest proportion of ions when the extraction was performed in the first hour after mixing (group A). Al- and F-values showed a highly significant positive correlation, independently from the curing time. We conclude that the biological assessment of dental cements can be performed only if a pre-evaluation of the leachables is obtained by applying a standardized protocol which allows a useful comparison between the different materials.
Savarino
L
L
Istituti Ortopedici Rizzoli, Bologna, Italy. lucia@savarino@ior.it
Cervellati
M
M
Stea
S
S
Cavedagna
D
D
Donati
M E
ME
Pizzoferrato
A
A
Visentin
M
M
D000535:Aluminum / Q000009:adverse effects / Q000493:pharmacokinetics*; D002327:Cariostatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D003731:Dental Caries / Q000517:prevention & control; D003738:Dental Cements / Q000009:adverse effects / Q000737:chemistry*; D005459:Fluorides / Q000009:adverse effects / Q000493:pharmacokinetics*; D005899:Glass Ionomer Cements / Q000009:adverse effects / Q000737:chemistry*; D006801:Humans; D066298:In Vitro Techniques; D008422:Materials Testing
D002327:Cariostatic Agents; D003738:Dental Cements; D005899:Glass Ionomer Cements; D000535:Aluminum; D005459:Fluorides